NASDAQ:DCTH

Delcath Systems Stock Predictions

Healthcare > Medical - Specialties

Buy DCTH

*Your capital is at risk

$10.33

-0.200 (-1.90%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

DCTH Prediction Chart

DCTH Predictions History

Latest community submissions for DCTH.

Predictor	Target Session	Target Price	Result	Direction	Accuracy
PeteKTF Merchant	Jan 25, 2017	$0.632 +54.11%	$0.410	X	45.90%
YoungBulls	Jan 25, 2017	$0.393 -4.17%	$0.410	X	95.90%
JS Pro	Jan 9, 2017	$0.534 -4.54%	$0.560	X	95.40%
Saadi.Malik.2153	Jan 9, 2017	$0.665 +18.88%	$0.560	X	81.20%

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for DCTH with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT DELCATH SYSTEMS, INC.

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS cli...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by